Patent · US Active

RGMC-selective inhibitors and use thereof

US12297262B2 · kind B2 · utility

0Cited by
2References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2019
Grant dateMay 13, 2025
Priority date
Expiry dateAug 1, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Selective inhibitors of repulsive guidance molecule C (RGMc), are described. Related methods, including methods for making, as well as therapeutic use of these inhibitors in the treatment of disorders, such as anemia, are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.